SmartVascular Dx™ Test: Enhancing Vascular Care in the Midwest IRVINE, Calif., June 25, 2025/GLOBE NEWSWIRE/–MorningStar Laboratories, LLC., (“MSL” or “the Company”), is a leading developer of precision diagnostic tests that address unmet clinical needs, is proud to announce its expansion in the Midwest with the introduction of the SmartVascular Dx™ test (formally known as the PULS™ […]
Expanding Access in California: SmartVascular Dx™ Test Now Available Through Major Health Plan IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) — MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, is excited to announce that theSmartVascular Dx™ test (formally known as the PULS™ Cardiac Test) is […]
SmartVascular™ Test: Revolutionizing Vascular Risk Assessment Nationwide IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) — MorningStar Laboratories, LLC (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly announces its SmartVascular Dx™ (SVDx) test (formally known as the PULS Cardiac test), designed to transform the early detection and management […]
